CytomX Therapeutics, Inc. (CTMX)
4.18
-0.16
(-3.69%)
USD |
NASDAQ |
Jan 13, 14:34
CytomX Therapeutics Price: 4.18 for Jan. 13, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| BioMarin Pharmaceutical, Inc. | 54.55 |
| NovaBay Pharmaceuticals, Inc. | 12.50 |
| Palatin Technologies, Inc. | 14.51 |
| Theriva Biologics, Inc. | 0.2101 |
| Oragenics, Inc. | 0.8867 |
Price Related Metrics
| PE Ratio | 9.995 |
| PS Ratio | 4.243 |
| PEG Ratio | 0.0682 |
| Price to Book Value | 6.595 |
| Earnings Yield | 10.00% |
| Market Cap | 708.24M |
| PEGY Ratio | 0.0682 |
| Operating PE Ratio | 20.83 |
| Normalized PE Ratio | 10.01 |